168 related articles for article (PubMed ID: 38459589)
61. Diagnostic features of tuberous sclerosis complex: case report and literature review.
Alshoabi SA; Hamid AM; Alhazmi FH; Qurashi AA; Abdulaal OM; Aloufi KM; Daqqaq TS
Quant Imaging Med Surg; 2022 Jan; 12(1):846-861. PubMed ID: 34993123
[TBL] [Abstract][Full Text] [Related]
62. Tuberous sclerosis complex misdiagnosed as multiple metastases in a cervical cancer patient: case report and literature review.
Ye T; Feng L; Peng M; Yuan S; Chen Y; Liu X; Chen J
Ann Palliat Med; 2021 Oct; 10(10):11232-11238. PubMed ID: 34763482
[TBL] [Abstract][Full Text] [Related]
63. A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity.
Wataya-Kaneda M; Tanaka M; Nakamura A; Matsumoto S; Katayama I
Br J Dermatol; 2011 Oct; 165(4):912-6. PubMed ID: 21692771
[TBL] [Abstract][Full Text] [Related]
64. Tuberous Sclerosis with Severe Cutaneous Manifestation and Multiples Facial Angiofibromas.
Garcia NG; de Carli ML; Oliveira DT; Soares CT; Ribeiro Júnior NV; Sperandio FF; Hanemann JA
Head Neck Pathol; 2016 Dec; 10(4):542-546. PubMed ID: 27140177
[TBL] [Abstract][Full Text] [Related]
65. Epithelial and Fibrous Hyperplasia: An Oral Manifestation of Tuberous Sclerosis Complex. A Case Study.
Mbibi SU; Segelnick SL; Weinberg MA
N Y State Dent J; 2015; 81(5):37-41. PubMed ID: 26521326
[TBL] [Abstract][Full Text] [Related]
66. Sporadic facial angiofibroma and sporadic angiomyolipoma mimicking tuberous sclerosis complex.
Klonowska K; Thiele EA; Grevelink JM; Thorner AR; Kwiatkowski DJ
J Med Genet; 2022 Sep; 59(9):920-923. PubMed ID: 34635572
[TBL] [Abstract][Full Text] [Related]
67. Effect of Angiofibromas on Quality of Life and Access to Care in Tuberous Sclerosis Patients and Their Caregivers.
Crall C; Valle M; Kapur K; Dies KA; Liang MG; Sahin M; Huang JT
Pediatr Dermatol; 2016 Sep; 33(5):518-25. PubMed ID: 27436143
[TBL] [Abstract][Full Text] [Related]
68. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis.
Hofbauer GF; Marcollo-Pini A; Corsenca A; Kistler AD; French LE; Wüthrich RP; Serra AL
Br J Dermatol; 2008 Aug; 159(2):473-5. PubMed ID: 18547304
[TBL] [Abstract][Full Text] [Related]
69. Tuberous Sclerosis Complex in a 17-month-old: A Case Report.
K C S; Bohaju A; Manandhar SR; Shrestha A; Aryal E; Maharjan P
JNMA J Nepal Med Assoc; 2023 Jun; 61(262):562-565. PubMed ID: 37464858
[TBL] [Abstract][Full Text] [Related]
70. Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas.
Fackler I; DeClue JE; Rust H; Vu PA; Kutzner H; Rütten A; Kaddu S; Sander CA; Volkenandt M; Johnson MW; Vinters HV; Wienecke R
J Cutan Pathol; 2003 Mar; 30(3):174-7. PubMed ID: 12641776
[TBL] [Abstract][Full Text] [Related]
71. Clinical Characteristics of Connective Tissue Nevi in Tuberous Sclerosis Complex With Special Emphasis on Shagreen Patches.
Bongiorno MA; Nathan N; Oyerinde O; Wang JA; Lee CR; Brown GT; Moss J; Darling TN
JAMA Dermatol; 2017 Jul; 153(7):660-665. PubMed ID: 28445558
[TBL] [Abstract][Full Text] [Related]
72. Racial differences in the dermatological manifestations of tuberous sclerosis complex and the potential effects on diagnosis and care.
Pounders AJ; Rushing GV; Mahida S; Nonyane BAS; Thomas EA; Tameez RS; Gipson TT
Ther Adv Rare Dis; 2022; 3():26330040221140125. PubMed ID: 37180419
[TBL] [Abstract][Full Text] [Related]
73. Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients.
Malissen N; Vergely L; Simon M; Roubertie A; Malinge MC; Bessis D
J Am Acad Dermatol; 2017 Sep; 77(3):464-472.e3. PubMed ID: 28502378
[TBL] [Abstract][Full Text] [Related]
74. Tuberous sclerosis complex (Bourneville-Pringle disease) in a 25-year- old female with bilateral renal angiomyolipoma and secondary hypertension.
El Aoud S; Frikha F; Snoussi M; Salah RB; Bahloul Z
Saudi J Kidney Dis Transpl; 2017; 28(3):633-638. PubMed ID: 28540905
[TBL] [Abstract][Full Text] [Related]
75. Fibrous papule of the face, similar to tuberous sclerosis complex-associated angiofibroma, shows activation of the mammalian target of rapamycin pathway: evidence for a novel therapeutic strategy?
Chan JY; Wang KH; Fang CL; Chen WY
PLoS One; 2014; 9(2):e89467. PubMed ID: 24558502
[TBL] [Abstract][Full Text] [Related]
76. Tuberous sclerosis with oral angiofibroma: case report.
Prabhu S; Mahesh KP
Br J Oral Maxillofac Surg; 2010 Apr; 48(3):205-7. PubMed ID: 19640621
[TBL] [Abstract][Full Text] [Related]
77. Intraoral desmoplastic fibroma: a manifestation of tuberous sclerosis.
Tandon S; Garg RK
Fetal Pediatr Pathol; 2012 Aug; 31(4):195-201. PubMed ID: 22404501
[TBL] [Abstract][Full Text] [Related]
78. Possible prevention of tuberous sclerosis complex lesions.
Kotulska K; Borkowska J; Jozwiak S
Pediatrics; 2013 Jul; 132(1):e239-42. PubMed ID: 23733802
[TBL] [Abstract][Full Text] [Related]
79. Clinicopathological investigation of odontogenic fibroma in tuberous sclerosis complex.
Musha A; Yokoo S; Takayama Y; Sato H
Int J Oral Maxillofac Surg; 2018 Jul; 47(7):918-922. PubMed ID: 29653868
[TBL] [Abstract][Full Text] [Related]
80. Coexistence of tuberous sclerosis complex and malignant melanoma.
Günaldi M; Paydas S; Afsar CU; Doran F
Singapore Med J; 2013 Nov; 54(11):e233-5. PubMed ID: 24276112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
